Patient Safety Matters with Use of Propofol in Critically Ill Patients

Editorial Open Access

Patient Safety Matters with Use of Propofol in Critically Ill Patients

Author Information
School of Nursing, Oregon Health & Science University, 3455 SW US Veterans Hospital Rd, Rm 521, Portland, OR 97239, USA
*
Authors to whom correspondence should be addressed.

Received: 01 November 2025 Revised: 03 November 2025 Accepted: 13 November 2025 Published: 19 November 2025

Creative Commons

© 2025 The authors. This is an open access article under the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).

Views:15
Downloads:5
Cardiovasc. Sci. 2025, 2(4), 10013; DOI: 10.70322/cvs.2025.10013
ABSTRACT: Despite its tendency to produce hypotension, propofol is used widely to induce general anesthesia and to facilitate endotracheal intubation in critically ill patients. Both dose reduction and routine co-administration of vasopressors have been used to offset this unfavorable hemodynamic effect in this subset of individuals. There are potential problems associated with each of these corrective measures, however, and criticism of other intravenous hypnotics used for this purpose—particularly etomidate—may be unwarranted. Choice of the appropriate pharmacology to induce anesthesia to assist with intubation should likely be based on individual clinical assessment, together with an understanding of the drug profile and realistic adverse effects.
Keywords: Patient safety; Intubation; Hypotension; Dose-reduced propofol; Etomidate
TOP